Stonepine Capital Management, LLC Atea Pharmaceuticals, Inc. Transaction History

Stonepine Capital Management, LLC

  • $158 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$2.8 - $3.35 $2.47 Million - $2.95 Million
-880,486 Reduced 51.19%
839,514 $2.56 Billion
Q3 2023

Nov 13, 2023
BUY
$3.0 - $3.79 $5.16 Million - $6.52 Million
1,720,000 New
1,720,000 $5.16 Billion
Q2 2023

Aug 11, 2023
BUY
$3.21 - $5.06 $216,931 - $341,954
67,580 Added 9.87%
752,088 $2.81 Million
Q1 2023

May 12, 2023
BUY
$3.0 - $4.97 $2.05 Million - $3.4 Million
684,508 New
684,508 $2.29 Million

Others Institutions Holding AVIR

# of Institutions
112
Shares Held
52.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $266M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email